<div id="readability-page-1"><ul><li>Zoom Video Indicates Normalization Ends and Growth Resumes</li></ul><p>Diageo, UP Fintech, Regencell Bioscience, China SXT Pharmaceuticals,  and Baiya International Group are the five Chinese stocks to watch today, according to MarketBeat's stock screener tool. &#34;Chinese stocks&#34; are shares of companies that are incorporated in or generate the majority of their revenue from mainland China, Hong Kong, or other Chinese jurisdictions. They trade on domestic exchanges (Shanghai, Shenzhen, Hong Kong) or abroad via listings such as H‑shares and ADRs, and carry country-specific considerations for investors including different share classes, regulatory regimes, currency and political risks, and varying market access. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.</p><h2>Diageo (DEO)</h2><p>Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.</p><ul><li>Modelo Sale Success Propels Constellation Brands In The Market</li></ul><p>Read Our Latest Research Report on DEO</p><h2>UP Fintech (TIGR)</h2><p>UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.</p><ul><li>3 Beer Stocks to Tap into if You're Ready for Some Football</li></ul><p>Read Our Latest Research Report on TIGR</p><h2>Regencell Bioscience (RGC)</h2><p>Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder.</p><p>Read Our Latest Research Report on RGC</p><h2>China SXT Pharmaceuticals (SXTC)</h2><p>China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.</p><p>Read Our Latest Research Report on SXTC</p><h2>Baiya International Group (BIYA)</h2><p>We, Baiya International Group Inc. (“Baiya”), are an offshore holding company incorporated in the Cayman Islands. We are not a Chinese operating company, but an offshore holding company incorporated in the Cayman Islands. As a holding company, we have no material operations and conduct all of our operations in China through the VIE, Shenzhen Gongwuyuan Network Technology Co., Ltd.</p><p>Read Our Latest Research Report on BIYA</p><h2>Featured Articles</h2><ul><li>MarketBeat's Top Five Stocks to Own in November 2025</li><li>Is Qualcomm Up 40% or Down 20%? 2 Contrarian Takes</li><li>Guardian Pharmacy Stock Pops on Q3 Strength and Upbeat Forecast</li><li>Rocket Lab Stock Jumps After Earnings, Despite Neutron Delay</li><li>Occidental Petroleum is a Buy in Q4 2025</li><li>3 Beaten-Down Stocks With Rebound Potential This Earnings Season</li></ul><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Diageo Right Now?</h2><p>Before you consider Diageo, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.</p><p>While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

SXTC

BIYA

TIGR

<p>MarketBeat's stock screener tool highlights five Chinese stocks to watch today: Diageo, UP Fintech, Regencell Bioscience, China SXT Pharmaceuticals, and Baiya International Group. These companies have the highest dollar trading volume among Chinese stocks recently. They operate in various sectors including alcoholic beverages, online brokerage, traditional Chinese medicine, and pharmaceuticals.</p>

Chinese Stocks To Follow Today - November 12th